TERUMO CORPORATION

4543・Prime Market・Precision Instruments

Official website

TERUMO CORPORATION

4543・Prime Market・Precision Instruments

Official website

TERUMO CORPORATION4543

Reference Indicators

Market Cap

32,957¥100M

P/E (Forecast)

19.9x

P/B

2.1x

Dividend Yield (Forecast)

1.62%

ROE

8.6%

EV/EBITDA

12.1x

Financial Summary

Unit: ¥M

Item	2022Mar 2022	2023Mar 2023	2024Mar 2024	2025Mar 2025	2026Mar 2026
Net Sales	703,303	820,209	921,863	1,036,171	1,131,877
Cost of Sales	333,962	402,839	442,688	475,501	537,201
Gross Profit	369,341	417,369	479,174	560,670	594,675
SG&A Expenses	250,891	299,861	344,979	381,648	409,937
Operating Income	115,960	117,332	140,096	157,668	176,320
Pre-tax Income	114,501	116,137	140,829	154,574	178,252
Income Taxes	25,687	26,811	34,455	37,595	42,337
Net Income	88,813	89,325	106,374	116,978	135,914
EBITDA	174,842	187,570	216,841	243,117	271,699
Gross Margin	52.5%	50.9%	52.0%	54.1%	52.5%
Operating Margin	16.5%	14.3%	15.2%	15.2%	15.6%
ROA	6.0%	5.6%	5.8%	6.4%	5.9%
ROE	8.8%	8.0%	8.0%	8.5%	8.6%

Segment Performance

Unit: ¥M

2026

Segment	Net Sales	Operating Income	Operating Margin
心臓血管カンパニー	676,421	163,994	24.2%
メディカルケアソリューションズカンパニー	216,138	21,568	10.0%
血液・細胞テクノロジーカンパニー	231,037	33,635	14.6%
オーガンテクノロジーズ事業	7,985	1,665	20.9%